Atara Biotherapeutics, Inc. (0HIY.L)
USD 10.43
(-0.02%)
USD 10.43
(-0.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -192.97 Million | -270.43 Million | -220.52 Million | -180.75 Million | -235.62 Million | -179.77 Million |
| Net Income | -276.12 Million | -228.3 Million | -340.14 Million | -306.62 Million | -290.97 Million | -230.69 Million |
| Depreciation & Amortization | 4.82 Million | 5.65 Million | 9.34 Million | 8.33 Million | 7.07 Million | 3.73 Million |
| Deferred income taxes | 5.13 Million | - | 1.79 Million | 958 Thousand | -303 Thousand | -1.88 Million |
| Stock-based compensation | 45.38 Million | 53.83 Million | 53.86 Million | 51.35 Million | 51.69 Million | 33.81 Million |
| Change in working capital | 15.34 Million | -61.46 Million | 52.58 Million | 63.68 Million | -4.14 Million | 15 Million |
| Other non-cash items | 12.45 Million | -40.15 Million | 2.03 Million | 1.53 Million | 1.03 Million | 260 Thousand |
| Investing Cash Flow | 123.86 Million | 202.95 Million | 22.25 Million | -120.72 Million | 60.45 Million | -196.28 Million |
| Investments in PPE | -1.22 Million | -4.19 Million | -10.58 Million | -4.51 Million | -5.73 Million | -35.92 Million |
| Acquisitions | 25 Thousand | 94.76 Million | -32.83 Million | 116.21 Million | 161 Thousand | - |
| Investment purchases | -83.64 Million | -180.58 Million | -301.12 Million | -425.86 Million | -270.23 Million | -466.48 Million |
| Sales/Maturities of investments | 208.71 Million | 292.97 Million | 333.96 Million | 309.65 Million | 336.26 Million | 306.12 Million |
| Other Investing Activities | 125.08 Million | 207.14 Million | 32.83 Million | -116.21 Million | 66.19 Million | -160.36 Million |
| Financing Cash Flow | 2 Million | 53.08 Million | 103.94 Million | 427.57 Million | 188.78 Million | 357.53 Million |
| Debt repayment | -947 Thousand | -518 Thousand | -254 Thousand | -389 Thousand | -486 Thousand | -528 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -94 Thousand | -623 Thousand | -1.24 Million | -1.52 Million | -6.69 Million | -7.5 Million |
| Common Stock Issuance | 3.06 Million | 23.81 Million | 105.45 Million | 422.96 Million | 188.61 Million | 365.56 Million |
| Other Financing Activities | -107 Thousand | 29.79 Million | 105.44 Million | 8.03 Million | 14.04 Million | 365.56 Million |
| Accounts receivables | 6.11 Million | -39.23 Million | 264 Thousand | -1.25 Million | - | - |
| Accounts payables | -3.13 Million | -9.21 Million | 9.06 Million | -815 Thousand | 4.21 Million | -1.95 Million |
| Inventory | -8.11 Million | -1.58 Million | 3.34 Million | -1.25 Million | - | - |
| Other working capital | 20.47 Million | -11.43 Million | 39.91 Million | 67 Million | -8.36 Million | 16.96 Million |
| Cash at beginning of period | 93.08 Million | 107.47 Million | 201.79 Million | 75.71 Million | 62.09 Million | 80.61 Million |
| Cash at end of period | 25.98 Million | 93.08 Million | 107.47 Million | 201.79 Million | 75.71 Million | 62.09 Million |
| Capital Expenditure | -1.22 Million | -4.19 Million | -10.58 Million | -4.51 Million | -5.73 Million | -35.92 Million |
| Effect of forex changes on cash | 1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -67.1 Million | -14.39 Million | -94.32 Million | 126.08 Million | 13.61 Million | -18.52 Million |
| Free Cash Flow | -194.2 Million | -274.62 Million | -231.1 Million | -185.27 Million | -241.35 Million | -215.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -19.04 Million | -31.75 Million | -60.45 Million | -276.12 Million | -69.79 Million | -71.1 Million |
| Depreciation & Amortization | 1.33 Million | 1.39 Million | 1.2 Million | 4.82 Million | 1.2 Million | 1.2 Million |
| Deferred income taxes | - | - | -52.2 Million | 5.13 Million | -214 Thousand | -755 Thousand |
| Stock-based compensation | 6.33 Million | 8.39 Million | 9.92 Million | 45.38 Million | 11.14 Million | 12.55 Million |
| Change in working capital | -3.38 Million | -11.73 Million | -7.27 Million | 15.34 Million | 1.97 Million | 1.09 Million |
| Other non-cash items | -20.02 Million | 24.19 Million | 58.39 Million | 12.45 Million | 4.34 Million | 4.22 Million |
| Investing Cash Flow | 7.19 Million | 14.71 Million | 9.94 Million | 123.86 Million | 70.44 Million | 49.48 Million |
| Investments in PPE | -29 Thousand | -127 Thousand | -44 Thousand | -1.22 Million | -281 Thousand | -499 Thousand |
| Acquisitions | - | - | -40.35 Million | 25 Thousand | 25 Thousand | -49.98 Million |
| Investment purchases | - | - | -1000.00 | -83.64 Million | -25 Thousand | -15.74 Million |
| Sales/Maturities of investments | 7.22 Million | 14.84 Million | 9.98 Million | 208.71 Million | 70.7 Million | 65.72 Million |
| Other Investing Activities | 7.22 Million | 14.84 Million | 40.35 Million | 125.08 Million | 25 Thousand | 49.98 Million |
| Financing Cash Flow | -324 Thousand | 24.14 Million | 1.51 Million | 2 Million | -208 Thousand | 471 Thousand |
| Debt repayment | -233 Thousand | -227 Thousand | -215 Thousand | -947 Thousand | -208 Thousand | -212 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -6000.00 | 94 Thousand | -94 Thousand | - | -1000.00 |
| Common Stock Issuance | -203 Thousand | 24.37 Million | 1.72 Million | 3.06 Million | - | -50 Thousand |
| Other Financing Activities | 112 Thousand | -6000.00 | 652 Thousand | -107 Thousand | 652 Thousand | 735 Thousand |
| Accounts receivables | 33.41 Million | -1.72 Million | -33.94 Million | 6.11 Million | 344 Thousand | -110 Thousand |
| Accounts payables | 2.39 Million | -826 Thousand | -2.81 Million | -3.13 Million | 2.46 Million | -894 Thousand |
| Inventory | -2.66 Million | -6.37 Million | -3.11 Million | -8.11 Million | 1.27 Million | -2.52 Million |
| Other working capital | -36.52 Million | -2.8 Million | 32.59 Million | 20.47 Million | -2.1 Million | 4.61 Million |
| Cash at beginning of period | 35.23 Million | 25.98 Million | 64.93 Million | 93.08 Million | 46.04 Million | 48.88 Million |
| Cash at end of period | 31.46 Million | 35.23 Million | 25.98 Million | 25.98 Million | 64.93 Million | 46.04 Million |
| Capital Expenditure | -29 Thousand | -127 Thousand | -44 Thousand | -1.22 Million | -281 Thousand | -499 Thousand |
| Effect of forex changes on cash | - | - | - | 1.00 | - | - |
| Net cash flow / Change in cash | -3.77 Million | 9.24 Million | -38.95 Million | -67.1 Million | 18.89 Million | -2.84 Million |
| Free Cash Flow | -10.67 Million | -29.73 Million | -50.45 Million | -194.2 Million | -51.62 Million | -53.29 Million |
6597
3370
ACNT
GPMT-PA
BTT
GBERY